Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
autologous adipose-derived stromal vascular fraction (Fodor)
- Development stage
- Unknown
- Lead developer
- Peter B. Fodor
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intraarticular
01
Overview
This autologous cell therapy involves the use of the stromal vascular fraction (SVF) derived from a patient's own adipose tissue. Developed by Dr. Peter B. Fodor, the procedure utilizes enzymatic disaggregation of lipoaspirate to isolate a heterogeneous cell population that includes mesenchymal stem cells, endothelial progenitor cells, and leukocytes. The therapy is administered via a single intra-articular injection into the knee joint, specifically targeting patients with Grade I-III osteoarthritis. It is designed to leverage the regenerative, anti-inflammatory, and immunomodulatory properties of the stromal cells to reduce pain and improve joint function.
- Other names
- ADSCSVFadipose-derived stromal cellsstromal vascular fractionautologous adipose-derived stromal vascular cells
Beyond the preview
Go deeper on autologous adipose-derived stromal vascular fraction (Fodor).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on autologous adipose-derived stromal vascular fraction (Fodor).